Relationship between small intestinal bacterial overgrowth and irritable bowel syndrome and the efficacy of rifaximin intervention: a systematic review and meta-analysis - PubMed
6 hours ago
- #rifaximin
- #small intestinal bacterial overgrowth
- #irritable bowel syndrome
- The pooled risk of SIBO is significantly higher in IBS patients compared to healthy controls (OR = 5.71).
- Rifaximin treatment achieves a pooled SIBO eradication rate of 59%, with medium-to-high doses (≥1,200 mg/day) showing slightly superior efficacy.
- GBT offers greater diagnostic stability and specificity for SIBO, while LBT provides broader sensitivity for distal overgrowth.